Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Vietnam ODM expert for comfort products

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Taiwan insole ODM full-service provider factory

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.Arch support insole OEM from Vietnam

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Orthopedic pillow OEM solutions Vietnam

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Indonesia ergonomic pillow OEM supplier

The image shows an artistic impression of the rocky scaffold structure of the nuclear pore complex filled with intrinsically disordered proteins in the central channel depicted as seaweeds. In this work, the scientists “dived” into the dark hole of the nuclear pore complex to shine light on the disordered proteins. Credit: Sara Mingu A Dynamic Network Within the Nuclear Envelope’s Pores Obstructs Dangerous Intruders Tiny pores within the cell nucleus are crucial to healthy aging, as they safeguard and maintain the DNA. A group from the Department of Theoretical Biophysics at the Max Planck Institute of Biophysics in Frankfurt am Main, Germany, and the Synthetic Biophysics of Protein Disorder Group at Johannes Gutenberg University Mainz has literally filled a hole in the understanding of the structure and function of these nuclear pores. In their study, the scientists elucidated the behavior of intrinsically disordered proteins located at the center of the pore. They found that these proteins form a mobile, spaghetti-like barrier. This barrier allows essential cellular factors to pass through while blocking viruses and other harmful pathogens. Human cells shield their genetic material inside the cell nucleus, protected by the nuclear membrane. As the control center of the cell, the nucleus must be able to exchange important messenger molecules, metabolites, or proteins with the rest of the cell. About 2000 pores are therefore built into the nuclear membrane, each consisting of about 1000 proteins. For decades, researchers have been fascinated by the three-dimensional structure and function of these nuclear pores, which act as guardians of the genome: substances that are required for controlling the cell are allowed to pass, while pathogens or other DNA-damaging substances are blocked from entry. The nuclear pores can therefore be thought of as molecular bouncers, each checking many thousands of visitors per second. Only those who have an entrance ticket are allowed to pass. How do the nuclear pores manage this enormous task? About 300 proteins attached to the pore scaffold protrude deep into the central opening like tentacles. Until now, researchers did not know how these tentacles are arranged and how they repel intruders. This is because these proteins are intrinsically disordered and lack a defined three-dimensional structure. They are flexible and continuously moving – like spaghetti in boiling water. Combination of Microscopy and Computer Simulations As these intrinsically disordered proteins (IDPs) are constantly changing their structure, it is difficult for scientists to decipher their three-dimensional architecture and their function. Most experimental techniques that researchers use to image proteins only work with a defined 3D structure. So far, the central region of the nuclear pore has been represented as a hole because it was not possible to determine the organization of the IDPs in the opening. The team led by Gerhard Hummer, Director at the Max Planck Institute of Biophysics, and Edward Lemke, Professor of Synthetic Biophysics at Johannes Gutenberg University Mainz, and Adjunct Director at the Institute of Molecular Biology Mainz has now used a novel combination of synthetic biology, multidimensional fluorescence microscopy and computer-based simulations to study nuclear pore IDPs in living cells. “We used modern precision tools to mark several points of the spaghetti-like proteins with fluorescent dyes that we excite by light and visualize in the microscope,” Lemke explains. “Based on the glow patterns and duration, we were able to deduce how the proteins must be arranged.” Hummer adds, “We then used molecular dynamics simulations to calculate how the IDPs are spatially organized in the pore, how they interact with each other, and how they move. For the first time, we could visualize the gate to the control center of human cells.” Dynamic Protein Network as a Transport Barrier The tentacles in the transport pore take on a completely different behavior compared to what we knew before, because they interact with each other and with the cargo. They move permanently like the aforementioned spaghetti in boiling water. So, in the center of the pore, there is no hole, but a shield of wiggly, spaghetti-like molecules. Viruses or bacteria are too big to get through this sieve. However, other large cellular molecules needed in the nucleus can pass as they carry very specific signals. Such molecules have an entry ticket, whereas pathogens usually do not. “By disentangling the pore filling, we enter a new phase in nuclear transport research,” adds Martin Beck, collaborator and colleague at the Max Planck Institute of Biophysics. “Understanding how the pores transport or block cargo will help us identify errors. After all, some viruses manage to enter the cell nucleus despite the barrier,” Hummer sums up. “With our combination of methods, we can now study IDPs in more detail to find why they are indispensable for certain cellular functions, despite being error-prone. In fact, IDPs are found in almost all species, although they carry the risk of forming aggregates during the aging process which can lead to neurodegenerative diseases such as Alzheimer’s,” Lemke says. By learning how IDPs function, researchers aim to develop new drugs or vaccines that prevent viral infections and help healthy aging. Reference: “Visualizing the disordered nuclear transport machinery in situ” by Miao Yu, Maziar Heidari, Sofya Mikhaleva, Piau Siong Tan, Sara Mingu, Hao Ruan, Christopher D. Reinkemeier, Agnieszka Obarska-Kosinska, Marc Siggel, Martin Beck, Gerhard Hummer and Edward A. Lemke, 26 April 2023, Nature. DOI: 10.1038/s41586-023-05990-0

A team of scientists in Isha Jain’s lab at Gladstone Institutes showed how chronically low oxygen levels, such as those experienced at 4,500 meters of elevation, rewire how mice burn sugars and fats. Credit: Michael Short/Gladstone Institutes When mice are subjected to sustained, low levels of oxygen similar to those found at an altitude of 4,500 meters, their metabolism changes. In comparison to individuals residing at sea level, the two million individuals worldwide residing at an elevation of 4,500 meters or higher (equivalent to the height of peaks such as Mount Rainier, Mount Whitney, and various peaks in Colorado and Alaska) have a lower incidence of metabolic diseases such as diabetes, coronary artery disease, hypercholesterolemia, and obesity. Researchers at the Gladstone Institutes have now shed light on this intriguing phenomenon. Through their study, they demonstrated how chronically low oxygen levels, such as those encountered at high elevations, alter the way mice burn sugars and fats. The findings, published in the journal Cell Metabolism, not only offer insights into the metabolic differences of individuals residing at high altitudes but also pave the way for the development of novel treatments for metabolic disease. “When an organism is exposed to chronically low levels of oxygen, we found that different organs reshuffle their fuel sources and their energy-producing pathways in various ways,” says Gladstone Assistant Investigator Isha Jain, Ph.D., senior author of the new study. “We hope these findings will help us identify metabolic switches that might be beneficial for metabolism even outside of low-oxygen environments.” Mimicking High Altitude Living Around sea level, where a third of the world’s population lives, oxygen makes up about 21 percent of the air we breathe. But people who live above 4,500 meters, where oxygen makes up just 11 percent of the air, can adapt to the shortage of oxygen—known as hypoxia—and thrive. Researchers studying the impact of hypoxia have typically carried out their research in isolated cells or within cancerous tumors, which often lack oxygen. Jain’s group wanted a more nuanced look at how long-term hypoxia impacts organs throughout the body. “We wanted to profile the metabolic changes that take place as an organism adapts to hypoxia,” says Ayush Midha, a graduate student in Jain’s lab and the first author of the new paper. “We thought this might provide some insight into how that adaptation protects against metabolic disease.” Midha, Jain, and their colleagues at Gladstone and UC San Francisco (UCSF) housed adult mice in pressure chambers containing either 21 percent, 11 percent, or 8 percent oxygen—all levels at which both humans and mice can survive. Over 3 weeks, they observed the animals’ behavior, monitored their temperature, carbon dioxide levels, and blood glucose, and used positron emission tomography (PET) scans to study how different organs were consuming nutrients. Redistributing Fuel In the first days of hypoxia, the mice living in 11 percent or 8 percent oxygen moved less, spending hours completely still. By the end of the third week, however, their movement patterns had returned to normal. Similarly, carbon dioxide levels in the blood—which decrease when mice or humans breathe faster to try to get more oxygen—initially decreased but returned to normal levels by the end of the 3 weeks. The animals’ metabolism, however, seemed more permanently altered by the hypoxia. For animals housed within the hypoxic cages, blood glucose levels and body weight both dropped, and neither returned to pre-hypoxic levels. In general, these more lasting changes mirror what has been seen in humans who live at high altitudes. When the researchers analyzed PET scans of each organ, they also discovered lasting changes. To metabolize fatty acids (the building blocks of fats) and amino acids (the building blocks of proteins), the body needs high levels of oxygen, while less oxygen is required to metabolize the sugar glucose. In most organs, hypoxia led to an increase in glucose metabolism—an expected response to the shortage of oxygen. But the scientists found that in brown fat and skeletal muscle—two organs that are already known for their high levels of glucose metabolism—levels of glucose consumption instead went down. “Prior to this study, the assumption in the field was that in hypoxic conditions, your whole body’s metabolism becomes more efficient in using oxygen, which means it burns more glucose and fewer fatty acids and amino acids,” says Jain, who is also an assistant professor in the Department of Biochemistry at UCSF. “We showed that while some organs are indeed consuming more glucose, others become glucose savers instead.” In retrospect, Jain says the observation makes sense; the isolated cells previously studied don’t need to make trade-offs to save glucose, while an entire animal, to survive, does. The lasting effects of long-term hypoxia seen in the mice— lower body weight and glucose levels—are both associated with a lower risk of diseases in humans, including cardiovascular disease. Understanding how hypoxia contributes to these changes could lead to new drugs that mimic these beneficial effects. With that goal in mind, Jain’s group hopes to follow up on this work with studies that look even more closely at how individual cell types and levels of signaling molecules change in different ways with hypoxia. Such research could point toward ways to mimic the protective metabolic effects of hypoxia with drugs—or high-altitude trips. “We already see athletes going to train at altitude to improve their athletic performance; maybe in the future, we’ll start recommending that people spend time at high altitude for other health reasons,” says Midha. Reference: “Organ-specific fuel rewiring in acute and chronic hypoxia redistributes glucose and fatty acid metabolism” by Ayush D. Midha, Yuyin Zhou, Bruno B. Queliconi, Alec M. Barrios, Augustinus G. Haribowo, Brandon T.L. Chew, Cyril O.Y. Fong, Joseph E. Blecha, Henry VanBrocklin, Youngho Seo and Isha H. Jain, 7 March 2023, Cell Metabolism. DOI: 10.1016/j.cmet.2023.02.007 The study was funded by the National Institute of General Medical Sciences, the National Institutes of Health, the Defense Advanced Research Projects Agency, the California Institute for Regenerative Medicine, and the National Science Foundation.

Novel kidney organoid recapitulating the patterned distribution of principal cells (red) and intercalated cells (green) of an adult kidney’s collecting duct system. Credit: Zipeng Zeng/Li Lab The organoids, which resemble a kidney’s uretic buds, provide a way to study kidney disease that could lead to new treatments and regenerative approaches for patients. A team of scientists at the Keck School of Medicine of USC has created what could be a key building block for assembling a synthetic kidney. In a new study in Nature Communications, Zhongwei Li and his colleagues describe how they can generate rudimentary kidney structures, known as organoids, that resemble the collecting duct system that helps maintain the body’s fluid and pH balance by concentrating and transporting urine. “Our progress in creating new types of kidney organoids provides powerful tools for not only understanding development and disease, but also finding new treatments and regenerative approaches for patients,” said Li, the study’s corresponding author and an assistant professor of medicine, and of stem cell biology and regenerative medicine. Zhongwei Li, PhD, Li Lab, USC Stem Cell. Credit: Richard Carrasco Creating the building blocks The first authors of the study, PhD student Zipeng Zeng and postdoc Biao Huang, and the team started with a population of what are known as ureteric bud progenitor cells, or UPCs, that play an important role in early kidney development. Using first mouse and then human UPCs, the scientists were able to develop cocktails of molecules that encourage the cells to form organoids resembling uretic buds — the branching tubes that eventually give rise to the collecting duct system. The scientists also succeeded in finding a different cocktail to induce human stem cells to develop into ureteric bud organoids. An additional molecular cocktail pushed ureteric bud organoids — grown from either mouse UPCs or human stem cells — to reliably develop into even more mature and complex collecting duct organoids. The human and mouse ureteric bud organoids can also be genetically engineered to harbor mutations that cause disease in patients, providing better models for understanding kidney problems, as well as for screening potential therapeutic drugs. As one example, the scientists knocked out a gene to create an organoid model of congenital anomalies of the kidney and urinary tract, known as CAKUT. In addition to serving as models of disease, ureteric bud organoids could also prove to be an essential ingredient in the recipe for a synthetic kidney. To explore this possibility, the scientists combined mouse ureteric bud organoids with a second population of mouse cells: the progenitor cells that form nephrons, which are the filtering units of the kidney. After inserting the tip of a lab-grown ureteric bud into a clump of NPCs, the team observed the growth of an extensive network of branching tubes reminiscent of a collecting duct system, fused with rudimentary nephrons. “Our engineered mouse kidney established a connection between nephron and collecting duct — an essential milestone towards building a functional organ in the future,” said Li. Reference: “Generation of patterned kidney organoids that recapitulate the adult kidney collecting duct system from expandable ureteric bud progenitors” by Zipeng Zeng, Biao Huang, Riana K. Parvez, Yidan Li, Jyunhao Chen, Ariel C. Vonk, Matthew E. Thornton, Tadrushi Patel, Elisabeth A. Rutledge, Albert D. Kim, Jingying Yu, Brendan H. Grubbs, Jill A. McMahon, Nuria M. Pastor-Soler, Kenneth R. Hallows, Andrew P. McMahon and Zhongwei Li, 15 June 2021, Nature Communications. DOI: 10.1038/s41467-021-23911-5 The project brought together scientists from the USC/UKRO Kidney Research Center, Li’s primary affiliation; the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC; the departments of Medicine, and Stem Cell Biology and Regenerative Medicine; and the divisions of Nephrology and Hypertension, and Maternal Fetal Medicine. Additional authors include Riana K. Parvez, Yidan Li, Jyunhao Chen, Ariel C. Vonk, Matthew E. Thornton, Tadrushi Patel, Elisabeth A. Rutledge, Albert D. Kim, Jingying Yu, Brendan H. Grubbs, Jill A. McMahon, Núria M. Pastor-Soler, Kenneth R. Hallows and Andrew P. McMahon. Twenty percent of this work was supported by federal funding from the National Institute of Diabetes and Digestive and Kidney Diseases (grant DK054364 and F31 fellowship DK107216). The remainder of the support came from departmental startup funding, UKRO foundation support, a USC Stem Cell Challenge Award, and the California Institute for Regenerative Medicine (CIRM) Bridges Program.

DVDV1551RTWW78V